Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience.
作者信息
Vittal Anusha, Alao Hawwa, Hercun Julian, Sharma Bashar, Khan Arsalan, Sharma Disha, Lee Wilson, Kapuria Devika, Hsieh Matthew, Tisdale John, Fitzhugh Courtney, Kleiner David, Levy Elliot, Chang Richard, Conrey Anna, Rivera Elenita, Huang Amy, Yakov Gil Ben, Kato Gregory J, Gladwin Mark T, Thein Swee Lay, Koh Christopher, Heller Theo
机构信息
Translational Hepatology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA.
Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
出版信息
Am J Hematol. 2022 Jul;97(7):E257-E260. doi: 10.1002/ajh.26560. Epub 2022 Apr 19.
Abstract
摘要
相似文献
1
Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience.镰状细胞相关肝病患者肝活检的安全性：单中心经验
Am J Hematol. 2022 Jul;97(7):E257-E260. doi: 10.1002/ajh.26560. Epub 2022 Apr 19.
2
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy.急性镰状细胞性肝病是经皮肝穿刺活检的潜在禁忌证。
Blood. 2003 Jan 1;101(1):101-3. doi: 10.1182/blood-2002-06-1823. Epub 2002 Aug 15.
3
Pathology of sickle cell disorders.镰状细胞疾病的病理学
Pathol Annu. 1983;18 Pt 2:253-76.
4
Chronic liver disease in a patient with sickle cell anemia.镰状细胞贫血患者的慢性肝病。
Turk J Gastroenterol. 2006 Jun;17(2):123-5.
5
Safety of liver biopsy in acute sickle hepatic crisis.急性镰状细胞性肝危象时肝活检的安全性
Conn Med. 2004 May;68(5):277-9.
6
Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood.镰状细胞病患者出现外周血红细胞吞噬现象的高溶血综合征。
Eur J Haematol. 2010 Feb 1;84(2):188. doi: 10.1111/j.1600-0609.2009.01351.x. Epub 2009 Sep 10.
7
Sickle cell hepatopathy.镰状细胞性肝病
South Med J. 1977 May;70(5):533-8. doi: 10.1097/00007611-197705000-00008.
8
Studies on the altered membrane characteristics of sickle cells.镰状细胞膜特性改变的研究。
FEBS Lett. 1978 Oct 1;94(1):81-6. doi: 10.1016/0014-5793(78)80911-9.
9
Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.镰状细胞病血管闭塞性危象的管理与预防研究
J Med. 1984;15(5-6):385-407.
10
Therapeutic agents for sickle cell disease.镰状细胞病的治疗药物。
Nature. 1978 Oct 5;275(5679):369-70. doi: 10.1038/275369a0.
引用本文的文献
1
Clinical Vignettes Part I.临床病例简述（一）
Hematol Oncol Clin North Am. 2022 Dec;36(6):1187-1199. doi: 10.1016/j.hoc.2022.08.001.
本文引用的文献
1
Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience.使用克拉茨金针经皮肝穿刺活检的并发症：36年单中心经验
Aliment Pharmacol Ther. 2017 Mar;45(5):744-753. doi: 10.1111/apt.13939. Epub 2017 Jan 10.
2
Liver injury is associated with mortality in sickle cell disease.肝脏损伤与镰状细胞病的死亡率相关。
Aliment Pharmacol Ther. 2015 Oct;42(7):912-21. doi: 10.1111/apt.13347. Epub 2015 Aug 3.
3
Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.异体造血干细胞移植治疗镰状细胞病：现在是时候了。
Blood. 2011 Aug 4;118(5):1197-207. doi: 10.1182/blood-2011-01-332510. Epub 2011 May 31.
4
Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review.经颈静脉肝活检——适应证、取材充分性、标本质量及并发症——一项系统评价
J Hepatol. 2007 Aug;47(2):284-94. doi: 10.1016/j.jhep.2007.05.001. Epub 2007 May 24.
5
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy.急性镰状细胞性肝病是经皮肝穿刺活检的潜在禁忌证。
Blood. 2003 Jan 1;101(1):101-3. doi: 10.1182/blood-2002-06-1823. Epub 2002 Aug 15.
Zotero 插件